{"transactions":[{"id":4862,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-09-04T22:00:03.000Z","date":"2026-09-04","kind":"sale","planned":false,"acquired":false,"shares":2137,"price":117.57,"value":251247.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.38 to $117.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":50254,"source":{"system":"sec-edgar","filing":"0001193125-26-383874","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526383874/ownership.xml","form_type":"4"}},{"id":4861,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-09-04T22:00:03.000Z","date":"2026-09-04","kind":"sale","planned":false,"acquired":false,"shares":3025,"price":116.81,"value":353350.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.09 to $117.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":52391,"source":{"system":"sec-edgar","filing":"0001193125-26-383874","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526383874/ownership.xml","form_type":"4"}},{"id":4860,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-09-04T22:00:03.000Z","date":"2026-09-04","kind":"sale","planned":false,"acquired":false,"shares":1209,"price":115.55,"value":139699.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not in the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.09 to $116.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":55416,"source":{"system":"sec-edgar","filing":"0001193125-26-383874","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526383874/ownership.xml","form_type":"4"}},{"id":861828,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-04T23:00:10.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":8250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this stock option shall vest in fourty-eight (48) equal monthly installments following March 2, 2026, subject to the reporting person's continued employment through each vesting date."}],"balance_after":8250,"derivative":{"exercise_price":90.1,"expiration_date":"2036-03-01","underlying":"Common Stock","underlying_shares":8250},"source":{"system":"sec-edgar","filing":"0001193125-26-091986","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526091986/ownership.xml","form_type":"4"}},{"id":861827,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-04T23:00:10.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":4125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following March 2, 2026, subject to the reporting person's continued employment through each vesting date."}],"balance_after":56625,"source":{"system":"sec-edgar","filing":"0001193125-26-091986","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526091986/ownership.xml","form_type":"4"}},{"id":1049891,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-03T21:05:04.000Z","date":"2025-09-03","kind":"grant","planned":false,"acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the shares underlying this stock option shall vest on September 3, 2026, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the reporting person's continued employment through each vesting date."}],"balance_after":105000,"derivative":{"exercise_price":43.3,"expiration_date":"2035-09-02","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001193125-25-195044","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312525195044/ownership.xml","form_type":"4"}},{"id":1049890,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-09-03T21:05:04.000Z","date":"2025-09-03","kind":"grant","planned":false,"acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following September 3, 2025, subject to the reporting person's continued employment through each vesting date."}],"balance_after":52500,"source":{"system":"sec-edgar","filing":"0001193125-25-195044","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312525195044/ownership.xml","form_type":"4"}},{"id":1079189,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-07-30T20:53:41.000Z","date":"2025-07-29","kind":"sale","planned":false,"acquired":false,"shares":18276,"price":3.68,"value":67255.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 42,393 shares of RSUs on July 28, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 144,611 shares underlying RSUs."}],"balance_after":371472,"source":{"system":"sec-edgar","filing":"0000950170-25-100364","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017025100364/ownership.xml","form_type":"4"}},{"id":1079188,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-07-30T20:53:41.000Z","date":"2025-07-28","kind":"sale","planned":false,"acquired":false,"shares":1637,"price":3.74,"value":6122.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,506 shares of restricted stock units (\"RSUs\") on July 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 187,004 shares underlying RSUs."}],"balance_after":389748,"source":{"system":"sec-edgar","filing":"0000950170-25-100364","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017025100364/ownership.xml","form_type":"4"}},{"id":1163400,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-05-01T00:23:52.000Z","date":"2025-04-30","kind":"sale","planned":false,"acquired":false,"shares":12943,"price":3,"value":38829.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 42,392 shares of RSUs on April 29, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 192,510 shares underlying RSUs."}],"balance_after":391385,"source":{"system":"sec-edgar","filing":"0000950170-25-061364","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017025061364/ownership.xml","form_type":"4"}},{"id":1163399,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-05-01T00:23:52.000Z","date":"2025-04-28","kind":"sale","planned":false,"acquired":false,"shares":1644,"price":3.17,"value":5211.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,505 shares of restricted stock units (\"RSUs\") on April 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 234,902 shares underlying RSUs."}],"balance_after":404328,"source":{"system":"sec-edgar","filing":"0000950170-25-061364","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017025061364/ownership.xml","form_type":"4"}},{"id":1188044,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-03-31T20:12:50.000Z","date":"2025-03-27","kind":"sale","planned":false,"acquired":false,"shares":298,"price":2.84,"value":846.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units (\"RSUs\") on March 26, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 240,407 shares underlying RSUs."}],"balance_after":405972,"source":{"system":"sec-edgar","filing":"0000950170-25-047717","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017025047717/ownership.xml","form_type":"4"}},{"id":1290826,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-01-31T02:02:57.000Z","date":"2025-01-30","kind":"sale","planned":false,"acquired":false,"shares":20791,"price":4.42,"value":91896.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 69,570 shares of RSUs on January 29, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 241,399 shares underlying RSUs."}],"balance_after":406270,"source":{"system":"sec-edgar","filing":"0000950170-25-011311","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017025011311/ownership.xml","form_type":"4"}},{"id":1290825,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-01-31T02:02:57.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":139141,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents RSUs granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 310,969 shares underlying RSUs."}],"balance_after":427061,"source":{"system":"sec-edgar","filing":"0000950170-25-011311","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017025011311/ownership.xml","form_type":"4"}},{"id":1290824,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-01-31T02:02:57.000Z","date":"2025-01-28","kind":"sale","planned":false,"acquired":false,"shares":33688,"price":4.63,"value":155975.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 105,505 shares of restricted stock units (\"RSUs\") on January 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 171,828 shares underlying RSUs."}],"balance_after":287920,"source":{"system":"sec-edgar","filing":"0000950170-25-011311","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017025011311/ownership.xml","form_type":"4"}},{"id":1303541,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-15T02:00:08.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments after January 10, 2025, subject to the reporting person's continued service with the Issuer through each vesting date."}],"balance_after":275000,"derivative":{"exercise_price":4.45,"expiration_date":"2035-01-09","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0000950170-25-005567","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017025005567/ownership.xml","form_type":"4"}},{"id":1319870,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-12-31T21:05:07.000Z","date":"2024-12-27","kind":"sale","planned":false,"acquired":false,"shares":299,"price":4.38,"value":1309.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units (\"RSUs\") on December 26, 2024. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 277,333 shares underlying RSUs."}],"balance_after":321608,"source":{"system":"sec-edgar","filing":"0000950170-24-141599","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017024141599/ownership.xml","form_type":"4"}},{"id":1379409,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-10-30T20:07:55.000Z","date":"2024-10-28","kind":"sale","planned":false,"acquired":false,"shares":1632,"price":6.06,"value":9889.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,506 shares of restricted stock units (\"RSUs\") on October 27, 2024. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 278,325 shares underlying RSUs."}],"balance_after":321907,"source":{"system":"sec-edgar","filing":"0000950170-24-118974","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017024118974/ownership.xml","form_type":"4"}},{"id":1396825,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-10-01T20:06:52.000Z","date":"2024-09-27","kind":"sale","planned":false,"acquired":false,"shares":295,"price":7.51,"value":2215.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units (\"RSUs\") on September 26, 2024. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 283,831 shares underlying RSUs."}],"balance_after":323539,"source":{"system":"sec-edgar","filing":"0000950170-24-110804","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017024110804/ownership.xml","form_type":"4"}},{"id":1445396,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-07-31T22:42:25.000Z","date":"2024-07-29","kind":"sale","planned":false,"acquired":false,"shares":1638,"price":8.85,"value":14496.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,505 shares of restricted stock units (\"RSUs\") on July 27, 2024. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 284,823 shares underlying RSUs."}],"balance_after":323834,"source":{"system":"sec-edgar","filing":"0000950170-24-088811","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017024088811/ownership.xml","form_type":"4"}},{"id":1465874,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-07-01T20:38:00.000Z","date":"2024-06-27","kind":"sale","planned":false,"acquired":false,"shares":295,"price":6.26,"value":1846.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units (\"RSUs\") on June 26, 2024. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 290,328 shares underlying RSUs."}],"balance_after":325472,"source":{"system":"sec-edgar","filing":"0000950170-24-079684","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017024079684/ownership.xml","form_type":"4"}},{"id":1533837,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-04-30T00:33:00.000Z","date":"2024-04-29","kind":"sale","planned":false,"acquired":false,"shares":1623,"price":6.38,"value":10354.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,505 shares of restricted stock units (\"RSUs\") on April 27, 2024. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 291,320 shares underlying RSUs."}],"balance_after":325767,"source":{"system":"sec-edgar","filing":"0000950170-24-050151","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017024050151/ownership.xml","form_type":"4"}},{"id":1557615,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-03-29T20:15:10.000Z","date":"2024-03-27","kind":"sale","planned":false,"acquired":false,"shares":348,"price":7.7,"value":2679.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units (\"RSUs\") on March 26, 2024. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 296,825 shares underlying RSUs."}],"balance_after":327390,"source":{"system":"sec-edgar","filing":"0000950170-24-038655","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000095017024038655/ownership.xml","form_type":"4"}},{"id":1665306,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-01-31T21:05:36.000Z","date":"2024-01-29","kind":"sale","planned":false,"acquired":false,"shares":1929,"price":9.64,"value":18595.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,506 shares of restricted stock units (\"RSUs\") on January 27, 2024. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 297,817 shares underlying RSUs."}],"balance_after":327738,"source":{"system":"sec-edgar","filing":"0001209191-24-002468","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919124002468/doc4.xml","form_type":"4"}},{"id":1676501,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-01-18T21:10:41.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 303,323 shares underlying RSUs."}],"balance_after":329667,"source":{"system":"sec-edgar","filing":"0001209191-24-001835","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919124001835/doc4.xml","form_type":"4"}},{"id":1698004,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-12-29T21:14:02.000Z","date":"2023-12-27","kind":"sale","planned":false,"acquired":false,"shares":294,"price":11.51,"value":3383.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units (\"RSUs\") on December 26, 2023. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 103,323 shares underlying RSUs."}],"balance_after":129667,"source":{"system":"sec-edgar","filing":"0001209191-23-059991","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919123059991/doc4.xml","form_type":"4"}},{"id":1752504,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-11-01T20:07:00.000Z","date":"2023-10-30","kind":"sale","planned":false,"acquired":false,"shares":1632,"price":6.03,"value":9840.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,505 shares of restricted stock units (\"RSUs\") on October 27, 2023. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 104,315 shares underlying RSUs."}],"balance_after":129961,"source":{"system":"sec-edgar","filing":"0001209191-23-054016","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919123054016/doc4.xml","form_type":"4"}},{"id":1771570,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-09-29T20:10:08.000Z","date":"2023-09-27","kind":"sale","planned":false,"acquired":false,"shares":294,"price":8.38,"value":2463.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units (\"RSUs\") on September 26, 2023. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 109,820 shares underlying RSUs."}],"balance_after":131593,"source":{"system":"sec-edgar","filing":"0001209191-23-050857","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919123050857/doc4.xml","form_type":"4"}},{"id":1820520,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-07-31T20:46:35.000Z","date":"2023-07-28","kind":"sale","planned":false,"acquired":false,"shares":1628,"price":11.8,"value":19210.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,506 shares of restricted stock units (\"RSUs\") on July 27, 2023. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 110,812 shares underlying RSUs."}],"balance_after":131887,"source":{"system":"sec-edgar","filing":"0001209191-23-043834","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919123043834/doc4.xml","form_type":"4"}},{"id":1842765,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-06-28T21:02:40.000Z","date":"2023-06-27","kind":"sale","planned":false,"acquired":false,"shares":294,"price":12.12,"value":3563.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 991 shares of restricted stock units (\"RSUs\") on June 26, 2023. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 116,318 shares underlying RSUs."}],"balance_after":133515,"source":{"system":"sec-edgar","filing":"0001209191-23-040054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919123040054/doc4.xml","form_type":"4"}},{"id":1872166,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-06-01T22:14:23.000Z","date":"2023-04-28","kind":"sale","planned":false,"acquired":false,"shares":1936,"price":11.16,"value":21605.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment is being filed to correct the number of shares sold to cover the reporting person's income tax withholding obligations upon the vesting of 5,504 shares of restricted stock units (\"RSUs\") on April 27, 2023, which was inadvertently understated in the reporting person's original Form 4. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Due to the error described above, the reporting person's original Form 4 incorrectly reported that the number of shares held by the reporting person was 134,882, including 120,359 shares underlying RSUs. As reported in this amendment, the correct number of shares held by the reporting person is 133,809, including 117,309 shares underlying RSUs."}],"balance_after":133809,"source":{"system":"sec-edgar","filing":"0001209191-23-033410","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919123033410/doc4a.xml","form_type":"4/A","original_submission_date":"2023-05-01"}},{"id":1910223,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-05-01T20:26:46.000Z","date":"2023-04-28","kind":"sale","planned":false,"acquired":false,"shares":863,"price":11.16,"value":9631.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 2,454 shares of restricted stock units (\"RSUs\") on April 27, 2023. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 120,359 shares underlying RSUs."}],"balance_after":134882,"source":{"system":"sec-edgar","filing":"0001209191-23-026271","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919123026271/doc4.xml","form_type":"4"}},{"id":1936949,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-03-28T20:47:48.000Z","date":"2023-03-27","kind":"sale","planned":false,"acquired":false,"shares":347,"price":15.36,"value":5329.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units (\"RSUs\") on March 26, 2023. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 122,813 shares underlying RSUs."}],"balance_after":135745,"source":{"system":"sec-edgar","filing":"0001209191-23-021414","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919123021414/doc4.xml","form_type":"4"}},{"id":2040439,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-01-31T21:15:58.000Z","date":"2023-01-30","kind":"sale","acquired":false,"shares":864,"price":21.56,"value":18627.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 2,454 shares of restricted stock units (\"RSUs\") on January 27, 2023. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 123,805 shares underlying RSUs."}],"balance_after":136092,"source":{"system":"sec-edgar","filing":"0001209191-23-005687","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919123005687/doc4.xml","form_type":"4"}},{"id":2050977,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-20T01:29:18.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":73220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Such option was granted pursuant to the terms of the Issuer's 2020 Stock Option and Incentive Plan and becomes exercisable, if at all, in twelve equal quarterly installments if the last quoted trading price per share of the Issuer's common stock on the Nasdaq Global Market during any fifteen consecutive calendar day period is at least $35.00; provided that the reporting person maintains a service relationship with the Issuer."}],"balance_after":73220,"derivative":{"exercise_price":20.45,"expiration_date":"2033-01-16","underlying":"Common Stock","underlying_shares":73220},"source":{"system":"sec-edgar","filing":"0001209191-23-004123","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919123004123/doc4.xml","form_type":"4"}},{"id":2050976,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-20T01:29:18.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":97630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments commencing on January 17, 2023, subject to the reporting person's continued service with the Issuer through each vesting date."}],"balance_after":97630,"derivative":{"exercise_price":20.45,"expiration_date":"2033-01-16","underlying":"Common Stock","underlying_shares":97630},"source":{"system":"sec-edgar","filing":"0001209191-23-004123","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919123004123/doc4.xml","form_type":"4"}},{"id":2050975,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-01-20T01:29:18.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":85425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 126,259 shares underlying RSUs."}],"balance_after":136956,"source":{"system":"sec-edgar","filing":"0001209191-23-004123","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919123004123/doc4.xml","form_type":"4"}},{"id":2054837,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-01-13T21:05:52.000Z","date":"2023-01-12","kind":"sale","acquired":false,"shares":9994,"price":20,"value":199880.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 04, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 40,834 shares underlying RSUs."}],"balance_after":51531,"source":{"system":"sec-edgar","filing":"0001209191-23-003272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919123003272/doc4.xml","form_type":"4"}},{"id":2075571,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-12-28T21:07:16.000Z","date":"2022-12-27","kind":"sale","acquired":false,"shares":295,"price":14.49,"value":4274.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units (\"RSUs\") on December 26, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 40,834 shares underlying RSUs."}],"balance_after":61525,"source":{"system":"sec-edgar","filing":"0001209191-22-062815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919122062815/doc4.xml","form_type":"4"}},{"id":2128520,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-11-01T21:56:15.000Z","date":"2022-10-28","kind":"sale","acquired":false,"shares":728,"price":21.54,"value":15681.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 2,455 shares of restricted stock units (\"RSUs\") on October 27, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 41,826 shares underlying RSUs."}],"balance_after":61820,"source":{"system":"sec-edgar","filing":"0001209191-22-055112","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919122055112/doc4.xml","form_type":"4"}},{"id":2149427,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-09-29T21:04:11.000Z","date":"2022-09-27","kind":"sale","acquired":false,"shares":294,"price":22.73,"value":6682.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units (\"RSUs\") on September 26, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 44,281 shares underlying RSUs."}],"balance_after":62548,"source":{"system":"sec-edgar","filing":"0001209191-22-051539","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919122051539/doc4.xml","form_type":"4"}},{"id":2200351,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-07-29T20:42:09.000Z","date":"2022-07-28","kind":"sale","acquired":false,"shares":734,"price":21.27,"value":15612.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 2,454 shares of restricted stock units (\"RSUs\") on July 27, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 45,273 shares underlying RSUs."}],"balance_after":62842,"source":{"system":"sec-edgar","filing":"0001209191-22-043534","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919122043534/doc4.xml","form_type":"4"}},{"id":2220256,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-06-28T21:56:03.000Z","date":"2022-06-27","kind":"sale","acquired":false,"shares":300,"price":20.31,"value":6093.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units (\"RSUs\") on June 26, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 47,727 shares underlying RSUs."}],"balance_after":63576,"source":{"system":"sec-edgar","filing":"0001209191-22-039656","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919122039656/doc4.xml","form_type":"4"}},{"id":2286585,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-05-03T00:03:02.000Z","date":"2022-04-28","kind":"sale","acquired":false,"shares":708,"price":25.57,"value":18103.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 2,454 shares of restricted stock units (\"RSUs\") on April 27, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 48,719 shares underlying RSUs."}],"balance_after":63876,"source":{"system":"sec-edgar","filing":"0001209191-22-026520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919122026520/doc4.xml","form_type":"4"}},{"id":2313038,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-03-31T21:37:47.000Z","date":"2022-03-29","kind":"sale","acquired":false,"shares":333,"price":29.87,"value":9946.71,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units (\"RSUs\") on March 26, 2022. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 51,173 shares underlying RSUs."}],"balance_after":64584,"source":{"system":"sec-edgar","filing":"0001209191-22-021814","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919122021814/doc4.xml","form_type":"4"}},{"id":2421189,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-31T22:13:32.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":78540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments commencing on January 27, 2022, subject to the reporting person's continued service with the Issuer through each vesting date."}],"balance_after":78540,"derivative":{"exercise_price":20.38,"expiration_date":"2032-01-26","underlying":"Common Stock","underlying_shares":78540},"source":{"system":"sec-edgar","filing":"0001209191-22-005645","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919122005645/doc4.xml","form_type":"4"}},{"id":2421188,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-01-31T22:13:32.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":39270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs shall vest in sixteen (16) equal quarterly installments commencing on January 27, 2022, subject to the reporting person's continued service with the Issuer through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 52,165 shares underlying RSUs."}],"balance_after":64917,"source":{"system":"sec-edgar","filing":"0001209191-22-005645","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919122005645/doc4.xml","form_type":"4"}},{"id":2440234,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-01-07T22:15:26.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":658,"price":26.1,"value":17173.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan (\"ESPP\") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on December 31, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 12,895 shares underlying RSUs."}],"balance_after":25647,"source":{"system":"sec-edgar","filing":"0001209191-22-002471","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919122002471/doc4.xml","form_type":"4"}},{"id":2458686,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-12-28T00:31:53.000Z","date":"2021-12-27","kind":"sale","acquired":false,"shares":295,"price":33.1,"value":9764.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units (\"RSUs\") on December 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 12,895 shares underlying RSUs."}],"balance_after":24989,"source":{"system":"sec-edgar","filing":"0001209191-21-071308","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919121071308/doc4.xml","form_type":"4"}},{"id":2510910,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-17T00:07:29.000Z","date":"2021-11-15","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty-five percent (25%) of the shares underlying this option vested on March 19, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date."}],"balance_after":140786,"derivative":{"exercise_price":4.12,"expiration_date":"2028-03-22","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001209191-21-064872","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919121064872/doc4.xml","form_type":"4"}},{"id":2510909,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-11-17T00:07:29.000Z","date":"2021-11-15","kind":"sale","acquired":false,"shares":6500,"price":35.42,"value":230230.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $35.03 to $35.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 13,887 shares underlying RSUs."}],"balance_after":25284,"source":{"system":"sec-edgar","filing":"0001209191-21-064872","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919121064872/doc4.xml","form_type":"4"}},{"id":2510908,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-11-17T00:07:29.000Z","date":"2021-11-15","kind":"exercise","acquired":true,"shares":6500,"price":4.12,"value":26780.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 13,887 shares underlying RSUs."}],"balance_after":31784,"source":{"system":"sec-edgar","filing":"0001209191-21-064872","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919121064872/doc4.xml","form_type":"4"}},{"id":2558959,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-09-28T01:21:06.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":293,"price":36.87,"value":10802.91,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units (\"RSUs\") on September 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 13,887 shares underlying RSUs."}],"balance_after":25284,"source":{"system":"sec-edgar","filing":"0001209191-21-057858","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919121057858/doc4.xml","form_type":"4"}},{"id":2572081,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-14T00:27:27.000Z","date":"2021-09-13","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-five percent (25%) of the shares underlying this option vested on March 19, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date."}],"balance_after":147286,"derivative":{"exercise_price":4.12,"expiration_date":"2028-03-22","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001209191-21-055784","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919121055784/doc4.xml","form_type":"4"}},{"id":2572080,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-09-14T00:27:27.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":6500,"price":35.02,"value":227630.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $35.00 to $35.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":25577,"source":{"system":"sec-edgar","filing":"0001209191-21-055784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919121055784/doc4.xml","form_type":"4"}},{"id":2572079,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-09-14T00:27:27.000Z","date":"2021-09-13","kind":"exercise","acquired":true,"shares":6500,"price":4.12,"value":26780.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020."}],"balance_after":32077,"source":{"system":"sec-edgar","filing":"0001209191-21-055784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919121055784/doc4.xml","form_type":"4"}},{"id":2650400,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-06-30T22:28:14.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":293,"price":35.81,"value":10492.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 991 shares of restricted stock units (\"RSUs\") on June 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 14,879 shares underlying RSUs."}],"balance_after":25577,"source":{"system":"sec-edgar","filing":"0001209191-21-044065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919121044065/doc4.xml","form_type":"4"}},{"id":2675967,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-10T00:37:39.000Z","date":"2021-06-07","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the shares underlying this option vested on March 19, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date."}],"balance_after":153786,"derivative":{"exercise_price":4.12,"expiration_date":"2028-03-22","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001209191-21-039328","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919121039328/doc4.xml","form_type":"4"}},{"id":2675966,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-06-10T00:37:39.000Z","date":"2021-06-07","kind":"sale","acquired":false,"shares":6500,"price":35,"value":227500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020."}],"balance_after":25870,"source":{"system":"sec-edgar","filing":"0001209191-21-039328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919121039328/doc4.xml","form_type":"4"}},{"id":2675965,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-06-10T00:37:39.000Z","date":"2021-06-07","kind":"exercise","acquired":true,"shares":6500,"price":4.12,"value":26780.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020."}],"balance_after":32370,"source":{"system":"sec-edgar","filing":"0001209191-21-039328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919121039328/doc4.xml","form_type":"4"}},{"id":2737368,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T01:15:06.000Z","date":"2021-04-26","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the shares underlying this option vested on March 19, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date."}],"balance_after":160286,"derivative":{"exercise_price":4.12,"expiration_date":"2028-03-22","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001209191-21-028861","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919121028861/doc4.xml","form_type":"4"}},{"id":2737367,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-04-29T01:15:06.000Z","date":"2021-04-26","kind":"sale","acquired":false,"shares":6500,"price":35,"value":227500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020."}],"balance_after":25870,"source":{"system":"sec-edgar","filing":"0001209191-21-028861","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919121028861/doc4.xml","form_type":"4"}},{"id":2737366,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-04-29T01:15:06.000Z","date":"2021-04-26","kind":"exercise","acquired":true,"shares":6500,"price":4.12,"value":26780.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020."}],"balance_after":32370,"source":{"system":"sec-edgar","filing":"0001209191-21-028861","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919121028861/doc4.xml","form_type":"4"}},{"id":2770736,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-26T23:59:59.000Z","date":"2021-03-26","kind":"grant","acquired":true,"shares":31740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments after March 26, 2021, subject to the reporting person's continued service with the Issuer through each vesting date."}],"balance_after":31740,"derivative":{"exercise_price":34.25,"expiration_date":"2031-03-25","underlying":"Common Stock","underlying_shares":31740},"source":{"system":"sec-edgar","filing":"0001209191-21-023331","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919121023331/doc4.xml","form_type":"4"}},{"id":2770735,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-03-26T23:59:59.000Z","date":"2021-03-26","kind":"grant","acquired":true,"shares":15870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs shall vest in sixteen (16) equal quarterly installments after March 26, 2021, subject to the reporting person's continued service with the Issuer through each vesting date."}],"balance_after":25870,"source":{"system":"sec-edgar","filing":"0001209191-21-023331","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919121023331/doc4.xml","form_type":"4"}},{"id":2890557,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-30T02:00:09.000Z","date":"2021-01-28","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the shares underlying this option vested on March 19, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date."}],"balance_after":166786,"derivative":{"exercise_price":4.12,"expiration_date":"2028-03-22","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-21-006365","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919121006365/doc4.xml","form_type":"4"}},{"id":2890556,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-01-30T02:00:09.000Z","date":"2021-01-28","kind":"sale","acquired":false,"shares":5000,"price":55.05,"value":275250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $55.00 to $55.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-21-006365","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919121006365/doc4.xml","form_type":"4"}},{"id":2890555,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-01-30T02:00:09.000Z","date":"2021-01-28","kind":"exercise","acquired":true,"shares":5000,"price":4.12,"value":20600.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001209191-21-006365","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919121006365/doc4.xml","form_type":"4"}},{"id":2944636,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-15T21:30:17.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":67588,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 2, 2020, the reporting person was granted an option to purchase 67,588 shares of common stock, subject to determination by the Board of Directors of the Issuer (the \"Board\") that the Issuer has met, in whole or in part, certain milestones (the \"2020 Option Grant Criteria\"). On June 23, 2020, the Board determined that the 2020 Option Grant Criteria related to 25% of the option had been achieved, and the shares underlying 25% of this option, or 16,897 shares, commenced vesting in sixteen (16) equal quarterly installments following September 23, 2020. On December 11, 2020, the Board determined that the 2020 Option Grant Criteria related to the remaining 75% of the option had been achieved. The shares underlying 75% of this option, or 50,691 shares, shall vest in sixteen (16) equal quarterly installments following March 11, 2021. Vesting of this option is subject to the reporting person's continued employment through each applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 2, 2020, the reporting person was granted an option to purchase 67,588 shares of common stock, subject to determination by the Board of Directors of the Issuer (the \"Board\") that the Issuer has met, in whole or in part, certain milestones (the \"2020 Option Grant Criteria\"). On June 23, 2020, the Board determined that the 2020 Option Grant Criteria related to 25% of the option had been achieved, and the shares underlying 25% of this option, or 16,897 shares, commenced vesting in sixteen (16) equal quarterly installments following September 23, 2020. On December 11, 2020, the Board determined that the 2020 Option Grant Criteria related to the remaining 75% of the option had been achieved. The shares underlying 75% of this option, or 50,691 shares, shall vest in sixteen (16) equal quarterly installments following March 11, 2021. Vesting of this option is subject to the reporting person's continued employment through each applicable vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On March 2, 2020, the reporting person was granted an option to purchase 67,588 shares of common stock, subject to determination by the Board of Directors of the Issuer (the \"Board\") that the Issuer has met, in whole or in part, certain milestones (the \"2020 Option Grant Criteria\"). On June 23, 2020, the Board determined that the 2020 Option Grant Criteria related to 25% of the option had been achieved, and the shares underlying 25% of this option, or 16,897 shares, commenced vesting in sixteen (16) equal quarterly installments following September 23, 2020. On December 11, 2020, the Board determined that the 2020 Option Grant Criteria related to the remaining 75% of the option had been achieved. The shares underlying 75% of this option, or 50,691 shares, shall vest in sixteen (16) equal quarterly installments following March 11, 2021. Vesting of this option is subject to the reporting person's continued employment through each applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On March 2, 2020, the reporting person was granted an option to purchase 67,588 shares of common stock, subject to determination by the Board of Directors of the Issuer (the \"Board\") that the Issuer has met, in whole or in part, certain milestones (the \"2020 Option Grant Criteria\"). On June 23, 2020, the Board determined that the 2020 Option Grant Criteria related to 25% of the option had been achieved, and the shares underlying 25% of this option, or 16,897 shares, commenced vesting in sixteen (16) equal quarterly installments following September 23, 2020. On December 11, 2020, the Board determined that the 2020 Option Grant Criteria related to the remaining 75% of the option had been achieved. The shares underlying 75% of this option, or 50,691 shares, shall vest in sixteen (16) equal quarterly installments following March 11, 2021. Vesting of this option is subject to the reporting person's continued employment through each applicable vesting date."}],"balance_after":67588,"derivative":{"exercise_price":5.22,"expiration_date":"2030-03-01","underlying":"Common Stock","underlying_shares":67588},"source":{"system":"sec-edgar","filing":"0001209191-20-063480","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000120919120063480/doc4.xml","form_type":"4"}},{"id":3078928,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2020-07-21T23:15:14.000Z","date":"2020-07-20","kind":"purchase","acquired":true,"shares":10000,"price":20,"value":200000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 20, 2020, the Reporting Person purchased 10,000 shares of common stock, par value $0.001 per share, of the Issuer at a price of $20.00 per share pursuant to an underwritten public offering."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000899243-20-019840","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1812364/000089924320019840/doc4.xml","form_type":"4"}},{"id":4052855,"issuer":{"id":161794,"kind":"organization","name":"KERYX BIOPHARMACEUTICALS INC","symbol":"KERX"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2018-02-16T16:04:08.000Z","date":"2018-02-15","kind":"sale","acquired":false,"shares":5652,"price":4.81,"value":27186.12,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Sale of a total of 5,652 shares of common stock was made in order to satisfy Mr. Adams' income tax withholding obligation upon the vesting of 16,251 shares of restricted stock on February 14, 2018. Mr. Adams had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 50,415 shares of restricted stock."}],"balance_after":126069,"source":{"system":"sec-edgar","filing":"0001114220-18-000021","document":"wf-form4_151881503397408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1114220/000111422018000021/wf-form4_151881503397408.xml","form_type":"4"}},{"id":4083831,"issuer":{"id":161794,"kind":"organization","name":"KERYX BIOPHARMACEUTICALS INC","symbol":"KERX"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2018-01-31T17:18:51.000Z","date":"2018-01-29","kind":"sale","acquired":false,"shares":1541,"price":4.81,"value":7412.21,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Sale of a total of 1,541 shares of common stock was made in order to satisfy Mr. Adams' income tax withholding obligation upon the vesting of 4,479 shares of restricted stock on January 26, 2018. Mr. Adams had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 66,666 shares of restricted stock."}],"balance_after":131721,"source":{"system":"sec-edgar","filing":"0001114220-18-000013","document":"wf-form4_151743711456240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1114220/000111422018000013/wf-form4_151743711456240.xml","form_type":"4"}},{"id":4104560,"issuer":{"id":161794,"kind":"organization","name":"KERYX BIOPHARMACEUTICALS INC","symbol":"KERX"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2018-01-08T18:06:22.000Z","date":"2018-01-05","kind":"sale","acquired":false,"shares":753,"price":4.69,"value":3531.57,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Sale of a total of 753 shares of common stock was made in order to satisfy Mr. Adams' income tax withholding obligation upon the vesting of 1,989 shares of restricted stock on January 4, 2018. Mr. Adams had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 71,145 shares of restricted stock."}],"balance_after":133262,"source":{"system":"sec-edgar","filing":"0001114220-18-000004","document":"wf-form4_151545276854523.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1114220/000111422018000004/wf-form4_151545276854523.xml","form_type":"4"}},{"id":4177778,"issuer":{"id":161794,"kind":"organization","name":"KERYX BIOPHARMACEUTICALS INC","symbol":"KERX"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2017-10-31T16:11:24.000Z","date":"2017-10-30","kind":"sale","acquired":false,"shares":1405,"price":6.03,"value":8472.15,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Sale of a total of 1,405 shares of common stock was made in order to satisfy Mr. Adams' income tax withholding obligation upon the vesting of 4,479 shares of restricted stock on October 27, 2017. Mr. Adams had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 73,134 shares of restricted stock."}],"balance_after":134015,"source":{"system":"sec-edgar","filing":"0001114220-17-000039","document":"wf-form4_150948067069170.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1114220/000111422017000039/wf-form4_150948067069170.xml","form_type":"4"}},{"id":4190404,"issuer":{"id":161794,"kind":"organization","name":"KERYX BIOPHARMACEUTICALS INC","symbol":"KERX"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2017-10-06T17:25:16.000Z","date":"2017-10-05","kind":"sale","acquired":false,"shares":630,"price":7.19,"value":4529.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Sale of a total of 630 shares of common stock was made in order to satisfy Mr. Adams' income tax withholding obligation upon the vesting of 1,989 shares of restricted stock on October 4, 2017. Mr. Adams had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 77,613 shares of restricted stock."}],"balance_after":135420,"source":{"system":"sec-edgar","filing":"0001114220-17-000032","document":"wf-form4_150732510244312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1114220/000111422017000032/wf-form4_150732510244312.xml","form_type":"4"}},{"id":4247620,"issuer":{"id":161794,"kind":"organization","name":"KERYX BIOPHARMACEUTICALS INC","symbol":"KERX"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2017-08-01T16:28:54.000Z","date":"2017-07-31","kind":"sale","acquired":false,"shares":1445,"price":7.14,"value":10317.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Sale of a total of 1,445 shares of common stock was made in order to satisfy Mr. Adams' income tax withholding obligation upon the vesting of 4,479 shares of restricted stock on July 28, 2017. Mr. Adams had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 79,602 shares of restricted stock."}],"balance_after":136050,"source":{"system":"sec-edgar","filing":"0001114220-17-000024","document":"wf-form4_150161932168614.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1114220/000111422017000024/wf-form4_150161932168614.xml","form_type":"4"}},{"id":4262472,"issuer":{"id":161794,"kind":"organization","name":"KERYX BIOPHARMACEUTICALS INC","symbol":"KERX"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2017-07-06T17:59:57.000Z","date":"2017-07-05","kind":"sale","acquired":false,"shares":641,"price":7.67,"value":4916.47,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Sale of a total of 641 shares of common stock was made in order to satisfy Mr. Adams' income tax withholding obligation upon the vesting of 1,989 shares of restricted stock on July 3, 2017. Mr. Adams had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 84,081 shares of restricted stock."}],"balance_after":137495,"source":{"system":"sec-edgar","filing":"0000899243-17-018004","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1114220/000089924317018004/doc4.xml","form_type":"4"}},{"id":4335884,"issuer":{"id":161794,"kind":"organization","name":"KERYX BIOPHARMACEUTICALS INC","symbol":"KERX"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2017-05-03T16:05:22.000Z","date":"2017-05-01","kind":"sale","acquired":false,"shares":1441,"price":5.97,"value":8602.77,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Sale of a total of 1,441 shares of common stock was made in order to satisfy Mr. Adams' income tax withholding obligation upon the vesting of 4,480 shares of restricted stock on April 28, 2017. Mr. Adams had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 86,070 shares of restricted stock."}],"balance_after":138136,"source":{"system":"sec-edgar","filing":"0000899243-17-011609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1114220/000089924317011609/doc4.xml","form_type":"4"}},{"id":4350892,"issuer":{"id":161794,"kind":"organization","name":"KERYX BIOPHARMACEUTICALS INC","symbol":"KERX"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2017-04-18T16:05:54.000Z","date":"2017-04-17","kind":"sale","acquired":false,"shares":1090,"price":5.75,"value":6267.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Sale of a total of 1,090 shares of common stock was made in order to satisfy Mr. Adams' income tax withholding obligation upon the vesting of 3,333 shares of restricted stock on April 14, 2017. Mr. Adams had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 90,550 shares of restricted stock."}],"balance_after":139577,"source":{"system":"sec-edgar","filing":"0000899243-17-010411","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1114220/000089924317010411/doc4.xml","form_type":"4"}},{"id":4357100,"issuer":{"id":161794,"kind":"organization","name":"KERYX BIOPHARMACEUTICALS INC","symbol":"KERX"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2017-04-06T16:05:31.000Z","date":"2017-04-05","kind":"sale","acquired":false,"shares":642,"price":5.8,"value":3723.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Sale of a total of 642 shares of common stock was made in order to satisfy Mr. Adams' income tax withholding obligation upon the vesting of 1,989 shares of restricted stock on April 4, 2017. Mr. Adams had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 93,883 shares of restricted stock."}],"balance_after":140667,"source":{"system":"sec-edgar","filing":"0000899243-17-009647","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1114220/000089924317009647/doc4.xml","form_type":"4"}},{"id":4384872,"issuer":{"id":161794,"kind":"organization","name":"KERYX BIOPHARMACEUTICALS INC","symbol":"KERX"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-03-15T18:28:17.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":97500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest according to the following schedule: one-third of the 97,500 options will vest on February 14, 2018 and one-twelfth will vest on each of May 14, 2018, August 14, 2018, November 14, 2018, February 14, 2019, May 14, 2019, August 14, 2019, November 14, 2019 and February 14, 2020."}],"balance_after":97500,"derivative":{"exercise_price":5.53,"exercise_date":"2018-02-14","expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":97500},"source":{"system":"sec-edgar","filing":"0000899243-17-007646","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1114220/000089924317007646/doc4.xml","form_type":"4"}},{"id":4384871,"issuer":{"id":161794,"kind":"organization","name":"KERYX BIOPHARMACEUTICALS INC","symbol":"KERX"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2017-03-15T18:28:17.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":48750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 48,750 shares are restricted common stock, with one-third of the 48,750 shares vesting on February 14, 2018 and one-twelfth vesting on each of May 14, 2018, August 14, 2018, November 14, 2018, February 14, 2019, May 14, 2019, August 14, 2019, November 14, 2019 and February 14, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 95,872 shares of restricted stock."}],"balance_after":141309,"source":{"system":"sec-edgar","filing":"0000899243-17-007646","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1114220/000089924317007646/doc4.xml","form_type":"4"}},{"id":4475862,"issuer":{"id":161794,"kind":"organization","name":"KERYX BIOPHARMACEUTICALS INC","symbol":"KERX"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2017-01-31T16:05:49.000Z","date":"2017-01-30","kind":"sale","acquired":false,"shares":6984,"price":4.65,"value":32475.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Sale of a total of 6,984 shares of common stock was made in order to satisfy Mr. Adams' income tax withholding obligation upon the vesting of 17,917 shares of restricted stock on January 27, 2017. Mr. Adams had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 47,122 shares of restricted stock."}],"balance_after":92559,"source":{"system":"sec-edgar","filing":"0000899243-17-002276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1114220/000089924317002276/doc4.xml","form_type":"4"}},{"id":4488793,"issuer":{"id":161794,"kind":"organization","name":"KERYX BIOPHARMACEUTICALS INC","symbol":"KERX"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and General Counsel"}}],"security":"Common Stock","published_at":"2017-01-18T16:05:24.000Z","date":"2017-01-17","kind":"sale","acquired":false,"shares":1265,"price":6.24,"value":7893.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Sale of a total of 1,265 shares of common stock was made in order to satisfy Mr. Adams' income tax withholding obligation upon the vesting of 3,333 shares of restricted stock on January 14, 2017. Mr. Adams had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 65,039 shares of restricted stock."}],"balance_after":99543,"source":{"system":"sec-edgar","filing":"0000899243-17-001438","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1114220/000089924317001438/doc4.xml","form_type":"4"}},{"id":4496835,"issuer":{"id":161794,"kind":"organization","name":"KERYX BIOPHARMACEUTICALS INC","symbol":"KERX"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and General Counsel"}}],"security":"Common Stock","published_at":"2017-01-06T16:06:08.000Z","date":"2017-01-05","kind":"sale","acquired":false,"shares":759,"price":6.16,"value":4675.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Sale of a total of 759 shares of common stock was made in order to satisfy Mr. Adams' income tax withholding obligation upon the vesting of 1,990 shares of restricted stock on January 4, 2017. Mr. Adams had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 68,372 shares of restricted stock."}],"balance_after":100808,"source":{"system":"sec-edgar","filing":"0000899243-17-000674","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1114220/000089924317000674/doc4.xml","form_type":"4"}},{"id":4578529,"issuer":{"id":161794,"kind":"organization","name":"KERYX BIOPHARMACEUTICALS INC","symbol":"KERX"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and General Counsel"}}],"security":"Common Stock","published_at":"2016-10-18T16:05:27.000Z","date":"2016-10-17","kind":"sale","acquired":false,"shares":1106,"price":4.86,"value":5375.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Sale of a total of 1,106 shares of common stock was made in order to satisfy Mr. Adams income tax withholding obligation upon the vesting of 3,333 shares of restricted stock on October 14, 2016. Mr. Adams had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 70,362 shares of restricted stock."}],"balance_after":101567,"source":{"system":"sec-edgar","filing":"0000899243-16-031825","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1114220/000089924316031825/doc4.xml","form_type":"4"}},{"id":4583614,"issuer":{"id":161794,"kind":"organization","name":"KERYX BIOPHARMACEUTICALS INC","symbol":"KERX"},"owners":[{"id":10235,"kind":"person","name":"Adams Brian","position":1,"cik":"0001636994","reported_name":"Adams Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and General Counsel"}}],"security":"Common Stock","published_at":"2016-10-06T16:05:35.000Z","date":"2016-10-05","kind":"sale","acquired":false,"shares":647,"price":5.38,"value":3480.86,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Sale of a total of 647 shares of common stock was made in order to satisfy Mr. Adams' income tax withholding obligation upon the vesting of 1,990 shares of restricted stock on October 4, 2016. Mr. Adams had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 73,695 shares of restricted stock."}],"balance_after":102673,"source":{"system":"sec-edgar","filing":"0000899243-16-031390","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1114220/000089924316031390/doc4.xml","form_type":"4"}}]}